NSE BSE
fortis healthcare ltd stock

FORTIS HEALTHCARE LTD Share Price

- - (%)
- NSE: FORTIS

FORTIS HEALTHCARE LTD Share Price Update

As of the latest trading session, FORTIS HEALTHCARE LTD share price is currently at 486.2, which is up by 5.80 from its previous closing. Today, the stock has fluctuated between 480.30 and 490.80. Over the past year, FORTIS HEALTHCARE LTD has achieved a return of 45.00 %. In the last month alone, the return has been 2.62 %. Read More...

FORTIS HEALTHCARE LTD Performance

Day Range

Low480.30 High490.80
486.10

52 Week Range

Low 308.50 High 509.85
486.10

FORTIS HEALTHCARE LTD Share Price

14592

532843

FORTIS

img img img img
No Data Available

Open Price

486.20

Prev. Close

480.40

Volume (Shares)

780235.00

Total traded value

3792.72

Upper Circuit

576.45

Lower Circuit

384.35

Note: The current prices & values are delayed, Login to your account for live updates.

FORTIS HEALTHCARE LTD Fundamentals


(Standalone)

Market Cap (Cr) 36706.07
PE Ratio (TTM) 181.84
Book Value / Share 120.36
Beta 0.46
ROE 1.37%
EPS (TTM) 1.64
Dividend Yield 0.21%
Net Profit Qtr (Cr) 68.33

FORTIS HEALTHCARE LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 307.48
Operating Expense 282.46
Net Profit 68.33
Net Profit Margin (%) 22.22
Earnings Per Share (EPS) 0.90
EBITDA 133.90
Effective Tax Rate (%) 23.74
Particulars DEC 2023 (Values in Cr)
Revenue 290.75
Operating Expense 286.63
Net Profit 22.94
Net Profit Margin (%) 7.88
Earnings Per Share (EPS) 0.30
EBITDA 80.41
Effective Tax Rate (%) 35.90
Particulars SEP 2023 (Values in Cr)
Revenue 294.12
Operating Expense 300.40
Net Profit 95.30
Net Profit Margin (%) 32.40
Earnings Per Share (EPS) 1.26
EBITDA 149.39
Effective Tax Rate (%) 7.92
Particulars JUN 2023 (Values in Cr)
Revenue 289.07
Operating Expense 302.01
Net Profit 12.88
Net Profit Margin (%) 4.45
Earnings Per Share (EPS) 0.17
EBITDA 65.76
Effective Tax Rate (%) 27.06
Particulars MAR 2023 (Values in Cr)
Revenue 277.47
Operating Expense 304.11
Net Profit 2.07
Net Profit Margin (%) 0.74
Earnings Per Share (EPS) 0.03
EBITDA 57.66
Effective Tax Rate (%) 40.51
Particulars MAR 2024 (Values in Cr)
Revenue 1181.42
Operating Expense 1171.51
Net Profit 199.45
Net Profit Margin (%) 16.88
Earnings Per Share (EPS) 2.64
EBITDA 429.46
Effective Tax Rate (%) 19.10
Particulars MAR 2023 (Values in Cr)
Revenue 1052.93
Operating Expense 1141.91
Net Profit 96.24
Net Profit Margin (%) 9.14
Earnings Per Share (EPS) 1.27
EBITDA 331.00
Effective Tax Rate (%) 11.60
Particulars MAR 2022 (Values in Cr)
Revenue 862.61
Operating Expense 989.42
Net Profit -13.25
Net Profit Margin (%) -1.53
Earnings Per Share (EPS) -0.18
EBITDA 233.22
Effective Tax Rate (%) -47.38
Particulars MAR 2021 (Values in Cr)
Revenue 632.87
Operating Expense 857.18
Net Profit 4.20
Net Profit Margin (%) 0.66
Earnings Per Share (EPS) 0.06
EBITDA 276.36
Effective Tax Rate (%) 82.59
Particulars MAR 2020 (Values in Cr)
Revenue 701.85
Operating Expense 890.88
Net Profit 513.33
Net Profit Margin (%) 73.13
Earnings Per Share (EPS) 6.80
EBITDA 877.65
Effective Tax Rate (%) 17.29
Particulars MAR 2024 (Values in Cr)
Book Value / Share 101.50
ROE % 7.81
ROCE % 9.65
Total Debt to Total Equity 0.14
EBITDA Margin 18.55
Particulars MAR 2023 (Values in Cr)
Book Value / Share 95.93
ROE % 6.79
ROCE % 7.51
Total Debt to Total Equity 0.16
EBITDA Margin 17.83
Particulars MAR 2022 (Values in Cr)
Book Value / Share 81.84
ROE % 7.45
ROCE % 7.75
Total Debt to Total Equity 0.23
EBITDA Margin 18.83
Particulars MAR 2021 (Values in Cr)
Book Value / Share 81.06
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.24
EBITDA Margin 11.99
Particulars MAR 2020 (Values in Cr)
Book Value / Share 88.23
ROE % 1.24
ROCE % 4.10
Total Debt to Total Equity 0.27
EBITDA Margin 14.11
Particulars MAR 2024 (Values in Cr)
Book Value / Share 120.37
ROE % 1.37
ROCE % 2.41
Total Debt to Total Equity 0.08
EBITDA Margin 27.42
Particulars MAR 2023 (Values in Cr)
Book Value / Share 118.73
ROE % 0.61
ROCE % 1.69
Total Debt to Total Equity 0.11
EBITDA Margin 25.99
Particulars MAR 2022 (Values in Cr)
Book Value / Share 117.47
ROE % 0.08
ROCE % 1.35
Total Debt to Total Equity 0.14
EBITDA Margin 27.88
Particulars MAR 2021 (Values in Cr)
Book Value / Share 117.64
ROE % -0.37
ROCE % 1.06
Total Debt to Total Equity 0.15
EBITDA Margin 33.62
Particulars MAR 2020 (Values in Cr)
Book Value / Share 117.58
ROE % 7.15
ROCE % 9.05
Total Debt to Total Equity 0.16
EBITDA Margin 140.42
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 598.39
Total Assets 13288.78
Total Liabilities 13288.78
Total Equity 8556.13
Share Outstanding 754958148
Price to Book Ratio 3.49
Return on Assets (%) 4.50
Return on Capital (%) 6.36
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 362.72
Total Assets 12433.60
Total Liabilities 12433.60
Total Equity 8100.38
Share Outstanding 754958148
Price to Book Ratio 2.19
Return on Assets (%) 4.73
Return on Capital (%) 6.69
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 412.69
Total Assets 11884.74
Total Liabilities 11884.74
Total Equity 7008.25
Share Outstanding 754958148
Price to Book Ratio 2.47
Return on Assets (%) 4.67
Return on Capital (%) 6.96
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 416.58
Total Assets 11154.68
Total Liabilities 11154.68
Total Equity 6717.81
Share Outstanding 754958148
Price to Book Ratio 1.69
Return on Assets (%) -0.98
Return on Capital (%) -1.37
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 265.95
Total Assets 11347.81
Total Liabilities 11347.81
Total Equity 7205.58
Share Outstanding 754958148
Price to Book Ratio 1.07
Return on Assets (%) 0.51
Return on Capital (%) 0.68
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 119.94
Total Assets 10386.91
Total Liabilities 10386.91
Total Equity 9087.16
Share Outstanding 754958148
Price to Book Ratio 3.49
Return on Assets (%) 1.92
Return on Capital (%) 2.12
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.03
Total Assets 10368.67
Total Liabilities 10368.67
Total Equity 8963.53
Share Outstanding 754958148
Price to Book Ratio 2.19
Return on Assets (%) 0.92
Return on Capital (%) 1.03
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.07
Total Assets 10426.20
Total Liabilities 10426.20
Total Equity 8868.56
Share Outstanding 754958148
Price to Book Ratio 2.47
Return on Assets (%) -0.12
Return on Capital (%) -0.14
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 3.50
Total Assets 10582.14
Total Liabilities 10582.14
Total Equity 8881.53
Share Outstanding 754958148
Price to Book Ratio 1.69
Return on Assets (%) 0.03
Return on Capital (%) 0.04
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 3.94
Total Assets 10580.85
Total Liabilities 10580.85
Total Equity 8876.46
Share Outstanding 754958148
Price to Book Ratio 1.07
Return on Assets (%) 4.85
Return on Capital (%) 5.36
Particulars MAR 2024 (Values in Cr)
Net Income 857.96
Cash from Operations 1321.90
Cash from Investing -886.36
Cash from Financing -86.45
Net change in Cash 124.51
Free Cash Flow 2331.70
Particulars MAR 2023 (Values in Cr)
Net Income 813.67
Cash from Operations 1096.47
Cash from Investing -373.69
Cash from Financing -471.22
Net change in Cash -21.43
Free Cash Flow 1557.60
Particulars MAR 2022 (Values in Cr)
Net Income 987.78
Cash from Operations 1076.76
Cash from Investing -514.37
Cash from Financing -517.31
Net change in Cash -166.23
Free Cash Flow 1292.25
Particulars MAR 2021 (Values in Cr)
Net Income 43.29
Cash from Operations 438.03
Cash from Investing -135.09
Cash from Financing -142.92
Net change in Cash 212.01
Free Cash Flow 656.54
Particulars MAR 2020 (Values in Cr)
Net Income 239.35
Cash from Operations 511.00
Cash from Investing 60.42
Cash from Financing -861.60
Net change in Cash -626.58
Free Cash Flow 666.89
Particulars MAR 2024 (Values in Cr)
Net Income 246.56
Cash from Operations 241.50
Cash from Investing 44.45
Cash from Financing -245.34
Net change in Cash 17.55
Free Cash Flow 566.13
Particulars MAR 2023 (Values in Cr)
Net Income 108.88
Cash from Operations 232.01
Cash from Investing 204.64
Cash from Financing -395.43
Net change in Cash 7.59
Free Cash Flow 285.66
Particulars MAR 2022 (Values in Cr)
Net Income -8.98
Cash from Operations 125.28
Cash from Investing 237.73
Cash from Financing -319.82
Net change in Cash -5.59
Free Cash Flow 152.10
Particulars MAR 2021 (Values in Cr)
Net Income 24.13
Cash from Operations 41.44
Cash from Investing 28.40
Cash from Financing 5.91
Net change in Cash 66.26
Free Cash Flow 97.77
Particulars MAR 2020 (Values in Cr)
Net Income 620.67
Cash from Operations 110.98
Cash from Investing 810.03
Cash from Financing -971.52
Net change in Cash -61.56
Free Cash Flow 135.39
Company Name Price P/E P/B Market Cap 52 Week Low/High
FORTIS HEALTHCARE LTD 480.05 61.78 4.72 36241.77 308.25 / 509.85
APOLLO HOSPITALS ENTER. L 6353.65 101.81 13.18 91355.74 4727.00 / 6871.30
FORTIS MALAR HOSPITALS LIMITED 63.75 0.00 1.09 119.48 44.00 / 107.94
SHREE PACETRONIX LTD. 189.70 20.33 5.24 68.28 138.00 / 391.90
TRANSGENE BIOTEK LTD. 10.35 0.00 7.32 78.42 3.62 / 12.46
Company Name Price P/E P/B Market Cap 52 Week Low/High
FORTIS HEALTHCARE LTD 480.05 292.71 3.98 36241.77 308.25 / 509.85
APOLLO HOSPITALS ENTER. L 6353.65 90.40 11.84 91355.74 4727.00 / 6871.30
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 35.46 0.00 -80.26 26.49 21.00 / 54.65
KOVAI MEDICAL CENTER & HOSPITA 4275.10 26.02 5.26 4676.96 2377.20 / 4777.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 470.00
  • 26 Days 468.30
  • 10 Days 469.20
  • 50 Days 465.00
  • 12 Days 470.20
  • 100 Days 452.70
  • 20 Days 473.50
  • 200 Days 350.90
479.72
PIVOT
First Resistance 490.08
Second Resistance 499.77
Third Resistance 510.13
First Support 470.03
Second Support 459.67
Third Support 449.98
RSI 47.02
MACD 1.85
Commodity Channel Index (CCI) 10.83
ADX 39.54
Williams % R -30.19

Over 1 Month

down

2.62

Over 3 Months

down

11.34

Over 6 Months

down

14.05

Over 1 Year

down

45.00

Over 3 Years

down

26.76

Over 5 Years

down

30.09

FORTIS HEALTHCARE LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

FORTIS HEALTHCARE LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
19.08
Promoter Holdings
31.16
FII
23.23
DII
26.51
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Northern Tk Venture Pte.ltd. Shareholding of Promoter and Promoter Group 2.35294117E8 31.17
Hdfc Large And Mid Cap Fund Public Shareholding 3.7142306E7 4.92
Rekha Jhunjhunwala Public Shareholding 3.0725E7 4.07
Aditya Birla Sun Life Trustee Private Limited A/c Public Shareholding 2.9694169E7 3.93
Mirae Asset Large & Midcap Fund Public Shareholding 2.7694232E7 3.67
Axis Mutual Fund Trustee Limited A/c Axis Mutual F Public Shareholding 2.0055938E7 2.66
Nippon Life India Trustee Ltd-a/c Nippon India Val Public Shareholding 1.8563822E7 2.46
Sbi Life Insurance Co. Ltd Public Shareholding 1.8336783E7 2.43
Sbi Nifty Midcap 150 Index Fund Public Shareholding 1.6532062E7 2.19
Kotak Focused Equity Fund Public Shareholding 1.6263311E7 2.15
Jupiter India Fund Public Shareholding 1.3218822E7 1.75
Fidelity Funds-india Focus Fund Public Shareholding 1.2581289E7 1.67
Sundaram Mutual Fund A/c Sundaram Multi Cap Fund Public Shareholding 1.0497389E7 1.39
Amansa Holdings Private Limited Public Shareholding 1.0461444E7 1.39
Kotak Funds - India Midcap Fund Public Shareholding 9998205.0 1.32
Axis Bank Limited Public Shareholding 9000000.0 1.19

FORTIS HEALTHCARE LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-07-20 1.0 Final 2023-07-20 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About FORTIS HEALTHCARE LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by FORTIS HEALTHCARE LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Fortis Healthcare Ltd?

Answer Field

The share price of Fortis Healthcare Ltd for NSE is ₹ 486.2 and for BSE is ₹ 485.5.

What is the Market Cap of Fortis Healthcare Ltd?

Answer Field

The market cap of Fortis Healthcare Ltd for NSE is ₹ 36,706.07 Cr. and for BSE is ₹ 36,653.21 Cr. as of now.

What is the 52 Week High and Low of Fortis Healthcare Ltd?

Answer Field

The 52 Week High and Low of Fortis Healthcare Ltd for NSE is ₹ 509.85 and ₹ 308.50 and for BSE is ₹ 509.85 and ₹ 308.25.

How to Buy Fortis Healthcare Ltd share?

Answer Field

You can trade in Fortis Healthcare Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Fortis Healthcare Ltd?

Answer Field

The 1 year returns on the stock has been 45.00%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader